Hepatitis B surface antigen (HBsAg) prevalence in Timor-Leste
Timor-Leste: Hepatitis B surface antigen (HBsAg) prevalence was 1.0% in 2024. ▼ Falling
Hepatitis B surface antigen (HBsAg) prevalence in Timor-Leste, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Timor-Leste is 1.0%, measured in 2024. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 28.6% on the previous year and down 69.7% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Timor-Leste peaked at 3.3% in 2015 and was at its lowest, 1.0%, in 2024.
That places Timor-Leste 31st out of 194 countries with data for 2024, putting it in the top quarter.
Hepatitis B surface antigen (HBsAg) prevalence in Timor-Leste, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 3.3% | — |
| 2016 | 2.8% | -15.2% |
| 2017 | 2.3% | -17.9% |
| 2018 | 2.1% | -8.7% |
| 2019 | 1.8% | -14.3% |
| 2020 | 1.5% | -16.7% |
| 2021 | 1.4% | -6.7% |
| 2022 | 1.4% | +0.0% |
| 2023 | 1.4% | +0.0% |
| 2024 | 1.0% | -28.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2.5% | 1.8% | 3.3% | 5 |
| 2020s | 1.3% | 1.0% | 1.5% | 5 |
Countries ranked near Timor-Leste
More health data for Timor-Leste
- Heat deaths vs projected death rates, annual growth rate 0.894 % change on previous year (2090)
- Un projection of annual infant deaths, annual growth rate -1.22 % change on previous year (2100)
- Heat deaths vs projected death rates 1,287 (2090)
- Un projection of annual infant deaths 162 (2100)
- Deaths in armed conflicts by region 0 (2026)
- Deaths in armed conflicts by country 0 (2026)
- Age population, age 09, female, interpolated 16,348 (2025)
- Age population, age 12, male, interpolated 15,603 (2025)
- Age population, age 12, female, interpolated 15,049 (2025)
- Age population, age 11, female, interpolated 15,503 (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Timor-Leste?
- Hepatitis b surface antigen (hbsag) prevalence in Timor-Leste was 1.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Timor-Leste?
- The highest recorded value was 3.3% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Timor-Leste?
- The lowest recorded value was 1.0% in 2024.
- How does Timor-Leste rank for hepatitis b surface antigen (hbsag) prevalence?
- Timor-Leste ranks 31st out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Timor-Leste?
- Over the last ten years it is down 69.7%. The long-run trend across the full record is falling.
- Where does this Timor-Leste data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).